載入...
Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy
Circulating Tumor Cells (CTCs) are commonly detected in the systemic blood of cancer patients with metastatic tumors. However, the mechanisms controlling the viability of cancer cells in blood and length of time spent in circulation, as well as their potential for generating additional tumors are st...
Na minha lista:
| 發表在: | Mol Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6279516/ https://ncbi.nlm.nih.gov/pubmed/30115759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-18-0302 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|